Literature DB >> 29456069

Arthroscopic Superior Capsular Reconstruction With Acellular Dermal Allograft for the Treatment of Massive Irreparable Rotator Cuff Tears: Short-Term Clinical Outcomes and the Radiographic Parameter of Superior Capsular Distance.

William T Pennington1, Brian A Bartz2, Joann M Pauli2, Carol E Walker2, William Schmidt2.   

Abstract

PURPOSE: This outcome analysis presents 88 consecutive shoulders presenting with irreparable rotator cuff tears that we treated with arthroscopic superior capsular reconstruction (SCR) using an acellular dermal allograft. We also present the concept of superior capsular distance to quantitatively measure the decreased distance present upon restoration of superior capsular integrity.
METHODS: A retrospective review was conducted of patients treated with arthroscopic SCR with a minimum 12-month follow-up. Outcome analysis was performed via an internet-based outcome-tracking system to evaluate visual analog scale (VAS) and American Shoulder and Elbow Surgeons (ASES) scores. Radiographic analysis of anteroposterior radiographs analyzed acromiohumeral interval and superior capsular distance. Digital dynamometric strength and functional range of motion assessments were also obtained. The main inclusion criteria for patients in this analysis was all patients who underwent superior capsular reconstruction during the time period of this report.
RESULTS: Eighty-six patients with an average age of 59.4 years presented with massive rotator cuff tears (Cofield >5 cm). Outcome data revealed improvement in VAS (4.0-1.5), and ASES (52-82) scores at 1 year (P = .005). Radiographic analysis showed increase in acromiohumeral interval (mean 7.1 mm preoperatively to mean 9.7 mm at 1 year) (P = .049) and superior capsular distance (mean 52.9 mm preoperatively to mean 46.2 mm at 1 year) (P = .011). Strength improved significantly (forward flexion/abduction/external rotation of 4.8/4.1/7.7 lb preoperatively to 9.8/9.2/12.3 lb at 1 year) as well as range of motion (forward flexion/abduction of 120°/103° preoperatively to 160°/159° at 1 year) (P = .044/P = .007/P = .02). At follow-up, 90% of patients were satisfied.
CONCLUSIONS: This analysis reveals that arthroscopic SCR with acellular dermal allograft has been successful in decreasing pain and improving function in this patient subset. Radiographic analysis has also shown a consistent and lasting decrease in superior capsular distance and increase in acromiohumeral interval, indicating maintenance of superior capsular stability. LEVEL OF EVIDENCE: Level IV, retrospective case series.
Copyright © 2018 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29456069     DOI: 10.1016/j.arthro.2018.01.009

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  48 in total

1.  Management of irreparable massive rotator cuff tears: a systematic review and meta-analysis of patient-reported outcomes, reoperation rates, and treatment response.

Authors:  David Kovacevic; Robert J Suriani; Brian M Grawe; Edward H Yian; Mohit N Gilotra; S Ashfaq Hasan; Umasuthan Srikumaran; Samer S Hasan; Frances Cuomo; Robert T Burks; Andrew G Green; Wesley M Nottage; Sai Theja; Hafiz F Kassam; Maarouf A Saad; Miguel A Ramirez; Rodney J Stanley; Matthew D Williams; Vidushan Nadarajah; Alexis C Konja; Jason L Koh; Andrew S Rokito; Charles M Jobin; William N Levine; Christopher C Schmidt
Journal:  J Shoulder Elbow Surg       Date:  2020-08-04       Impact factor: 3.019

2.  Can inadequate acromiohumeral distance improvement and poor posterior remnant tissue be the predictive factors of re-tear? Preliminary outcomes of arthroscopic superior capsular reconstruction.

Authors:  Seung-Jun Lee; Young-Kyoung Min
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-28       Impact factor: 4.342

3.  Significant improvement in patient self-assessed comfort and function at six weeks after the smooth and move procedure for shoulders with irreparable rotator cuff tears and retained active elevation.

Authors:  Frederick A Matsen; Anastasia Whitson; Sarah E Jackins; Jason E Hsu
Journal:  Int Orthop       Date:  2019-03-22       Impact factor: 3.075

4.  Arthroscopic single-row repair of massive potentially irreparable postero-superior cuff tear.

Authors:  S Carbone; C Razzano; D Passaretti; R Mezzoprete
Journal:  Musculoskelet Surg       Date:  2018-10-20

5.  Treatment of Massive Irreparable Rotator Cuff Tear with Arthroscopic Subacromial Bursectomy, Biceps tenotomy, and Tuberoplasty.

Authors:  Fateme Mirzaee; Mohammad A Aslani; Zohreh Zafarani; Hamidreza Aslani
Journal:  Arch Bone Jt Surg       Date:  2019-05

6.  Latissimus Dorsi Tendon Transfer and Superior Capsular Reconstruction for Irreparable, Posterosuperior Rotator Cuff Tears.

Authors:  Tiffany R Kadow; Sean J Meredith; Daniel Garcia; Rebecca Minorini; Ruth Delaney; Mark Baratz; Albert Lin
Journal:  Arch Bone Jt Surg       Date:  2021-01

Review 7.  [Research progress of indication and treatment of graft in shoulder superior capsular reconstruction for rotator cuff tear].

Authors:  Huaisheng Li; Mingyu Yang; Yan Li; Binghua Zhou; Kanglai Tang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-02-15

8.  [Research progress of treatment for massive rotator cuff tears].

Authors:  Xiaolong Zheng; Kanglai Tang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

9.  Failure Rate After Superior Capsular Reconstruction With Achilles Tendon-Bone Allograft for Irreparable Rotator Cuff Tears.

Authors:  Erica Kholinne; Yucheng Sun; Jae-Man Kwak; Hyojune Kim; Kyoung Hwan Koh; In-Ho Jeon
Journal:  Orthop J Sports Med       Date:  2021-05-05

Review 10.  Rehabilitation Protocols for Superior Capsular Reconstruction Are Variable: A Systematic Review.

Authors:  Alessia C Lavin; Kailey L Mansour; Dylan N Greif; Brandon J Shallop; Paul R Allegra; Rafael A Sanchez; Julianne Muñoz; Michael G Baraga
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.